Skip to main content
FinSpry Logo
FinSpry
CATX logo
CATX
(NYSEAMERICAN)
Perspective Therapeutics, Inc.
$4.41-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Perspective Therapeutics (CATX) Stock Price & Financial Analysis

Perspective Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$4.22 - $4.56
52-Week High$6.16
52-Week Low$1.60
Open$4.28
Volume1.05M
Average Volume (3M)1.05M
Market Cap327.65M
Shares Outstanding74.30M
Price to Sales (P/S)390.47
Price to Book (P/B)1.36
EV/EBITDA-2.88
Revenue (TTM)841.00K
Net Income (TTM)-105.80M
Free Cash Flow (TTM)-106.72M
EPS (TTM)$-1.42
Profit Margin-12580.26%
Operating Margin-11251.72%
Return on Equity (ROE)-43.68%
Debt to Equity0.01
50-Day MA$4.61
200-Day MA$3.57
52-Week Change125.51%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Perspective Therapeutics

What is the current stock price for CATX?

As of the latest trading session, CATX stock trades at $4.41. The 52-week range is $1.60–$6.16, with a day range of $4.22–$4.56.

What is the P/E ratio for CATX?

The P/E ratio (Price-to-Earnings) for CATX is shown in the Key Statistics section. This valuation metric helps compare Perspective Therapeutics, Inc. to industry peers.

Does CATX pay dividends?

Perspective Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CATX?

Based on 11 analysts, the consensus for CATX is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of CATX?

Perspective Therapeutics's market capitalization is $327.6M, classifying it as a small-cap company. Perspective Therapeutics operates in the Healthcare sector within the Medical Devices industry.